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Background
A goal of HIV-1 vaccine development is to induce
broadly neutralizing antibodies. However, the Env com-
plex is poorly immunogenic and requires potent adju-
vants. Given the pivotal role of TLRs and DCs in
initiating and tuning adaptive immune responses, TLR
agonists are attractive adjuvants. CD14+ dermal DCs
(CD14+ DDCs) have a natural capacity to stimulate
naïve B-cells, so targeting these cells with TLR ligands is
a rational approach to inducing humoral responses.
Methods
Migratory cells were collected after culturing skin for 24
h. CD14+ DDCs were purified using CD14 magnetic
beads, stimulated with TLR ligand(s) and analyzed for
cytokine expression (ELISA/qPCR) and phenotype after
48 h. Naïve B-cells were stimulated with TLR ligand(s)
plus CD40L and IL-2, either alone or in the presence of
CD14+ DDCs, and analyzed for proliferation, phenotype
and IgG/IgA secretion. TLR-ligand stimulated DDCs
were incubated with allogeneic naive CD4+ T-cells for 6
days before T-cell derived cytokines were quantified.
Results
CD14+ DDCs express mRNA for TLRs 1−9, but
respond differentially to single or paired TLR ligands.
Compared to single ligands, some combinations were
particularly effective, increasing the expression of B-cell
stimulatory cytokines and maturation of the DDCs.
These combinations were R-848 plus Poly(I:C); R-848
plus LPS; Pam3CSK4 plus Poly(I:C); LPS plus Poly(I:C).
Selected TLR agonist pairs (R-848 plus either LPS or
Poly(I:C)) were superior to individual agents at boosting
the capacity of CD14+ DDCs to induce naïve B-cells to
proliferate and differentiate into CD27+CD38+ B-cells
that secrete high levels of IgG and IgA. These selected
TLR ligand combinations also induced CD14+ DDCs to
promote differentiation of Th1, but not Th2, Th17 or
TFH cells.
Conclusion
Two TLR ligand combinations potently activate CD14+
DDCs to have enhanced B-cell stimulatory capacity, and
could be used to improve humoral immune responses
to HIV-1 Env.
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